PL04.13 Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer: Interim Results of the Phase III Study (POLESTAR)Jinming Yu, Chunyu Liu, Xue Meng et al.|Journal of Thoracic Oncology|2024Cited by 17
P79.02 Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLCC. Zhou, Chengping Hu, Lizhu Lin et al.|Journal of Thoracic Oncology|2021Cited by 7